DENICE HERNANDEZ: Open Payments
NPI 1467220251 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 13 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $379 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $36 |
| PFIZER INC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Corium, LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: BEXSERO, Wegovy, REXULTI, Tirosint, MOUNJARO, STRENSIQ, ELIQUIS, CAPVAXIVE.
Industry payments across NJ — which companies pay providers there.
